Wells Fargo & Company Pa Vmed Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.22 - $0.5 $10,400 - $23,638	-47,277 Reduced 13.55%	301,596 $90,000
Q2 2023 Aug 15, 2023	BUY	$0.35 - $0.56 $31 - $50	90 Added 0.03%	348,873 $143,000
Q1 2023 May 12, 2023	SELL	$0.36 - $0.63 $6,403 - $11,205	-17,787 Reduced 4.85%	348,783 $129,000
Q4 2022 Feb 13, 2023	BUY	$0.41 - $18.6 $23,588 - $1.07 Million	57,533 Added 18.62%	366,570 $175,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $34.65 $95,478 - $5.8 Million	167,507 Added 118.35%	309,037 $265,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.41 $49,639 - $82,342	-58,399 Reduced 29.21%	141,530 $132,000
Q1 2022 May 16, 2022	BUY	$1.16 - $2.5 $46,123 - $99,405	39,762 Added 24.83%	199,929 $264,000
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $47,615 - $169,171	-19,356 Reduced 10.78%	160,167 $394,000
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $26,647 - $49,062	-5,225 Reduced 2.83%	179,523 $1.53 Million
Q2 2021 Aug 16, 2021	SELL	$3.95 - $6.88 $230,340 - $401,200	-58,314 Reduced 23.99%	184,748 $1.18 Million
Q1 2021 May 13, 2021	BUY	$2.01 - $5.55 $44,947 - $124,109	22,362 Added 10.13%	243,062 $1.08 Million
Q4 2020 Feb 09, 2021	BUY	$1.73 - $2.13 $154,772 - $190,558	89,464 Added 68.17%	220,700 $468,000
Q3 2020 Nov 05, 2020	BUY	$1.76 - $2.17 $139,363 - $171,829	79,184 Added 152.12%	131,236 $234,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.65 $90,867 - $137,598	51,924 Added 40565.63%	52,052 $110,000
Q1 2020 May 14, 2020	BUY	$1.15 - $3.29 $147 - $421	128 New	128 $0

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.